Pure Global

Qualitative RNA Test for SARS-CoV-2 - Vietnam Registration 2200106ĐKLH/BYT-TB-CT

Access comprehensive regulatory information for Qualitative RNA Test for SARS-CoV-2 in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại D medical device is registered under number 2200106ĐKLH/BYT-TB-CT and manufactured by SD Biosensor Inc..

This page provides complete technical specifications, regulatory compliance details, 2 companies making similar products including SolGent Co., Ltd., Bioneer Corporation, and 2 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
2 Competitors
2 Recent Registrations
2200106ĐKLH/BYT-TB-CT
Registration Details
Vietnam MOH Registration: 2200106ĐKLH/BYT-TB-CT
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Qualitative RNA Test for SARS-CoV-2
VN: Thuốc thử xét nghiệm định tính RNA của SARS-CoV-2
STANDARDTM M nCoV Real-Time Detection Kit
Risk Class TTBYT Loại D

Registration Details

2200106ĐKLH/BYT-TB-CT

000.00.04.G18-220328-0023

STANDARD™ M nCoV Real-Time Detection Kit

Mã REF: M-NCOV-01 / Mã Catalog : 11NCO10

Company Information

REPUBLIC OF

Technical Details

The STANDARD™ M nCoV Real-Time Detection kit is used to detect and identify the ORF1ab (RdRp) and E genes of SARS-CoV-2 in throat swab, nasal swab, and sputum samples, based on the principle of reverse transcription real-time PCR. This kit is useful in assisting the diagnosis of COVID-19. The test results are only for clinical reference and should not be used as the sole basis for diagnosis or exclusion.

Dates and Status

Nov 15, 2022

Companies Making Similar Products
Companies providing products similar to "Qualitative RNA Test for SARS-CoV-2"